Hedgehog signalling within airway epithelial progenitors and in small-cell lung cancer

被引:0
|
作者
D. Neil Watkins
David M. Berman
Scott G. Burkholder
Baolin Wang
Philip A. Beachy
Stephen B. Baylin
机构
[1] Johns Hopkins University School of Medicine,Sidney Kimmel Comprehensive Cancer Center
[2] Johns Hopkins University School of Medicine,Department of Pathology
[3] Johns Hopkins University School of Medicine,Department of Molecular Biology and Genetics, and Howard Hughes Medical Institute
来源
Nature | 2003年 / 422卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Embryonic signalling pathways regulate progenitor cell fates in mammalian epithelial development and cancer1,2. Prompted by the requirement for sonic hedgehog (Shh) signalling in lung development3,4, we investigated a role for this pathway in regeneration and carcinogenesis of airway epithelium. Here we demonstrate extensive activation of the hedgehog (Hh) pathway within the airway epithelium during repair of acute airway injury. This mode of Hh signalling is characterized by the elaboration and reception of the Shh signal within the epithelial compartment, and immediately precedes neuroendocrine differentiation. We reveal a similar pattern of Hh signalling in airway development during normal differentiation of pulmonary neuroendocrine precursor cells, and in a subset of small-cell lung cancer (SCLC), a highly aggressive and frequently lethal human tumour with primitive neuroendocrine features. These tumours maintain their malignant phenotype in vitro and in vivo through ligand-dependent Hh pathway activation. We propose that some types of SCLC might recapitulate a critical, Hh-regulated event in airway epithelial differentiation. This requirement for Hh pathway activation identifies a common lethal malignancy that may respond to pharmacological blockade of the Hh signalling pathway.
引用
收藏
页码:313 / 317
页数:4
相关论文
共 50 条
  • [41] Neuroendocrine and epithelial phenotypes in small-cell lung cancer: implications for metastasis and survival in patients
    R Stovold
    S L Meredith
    J L Bryant
    M Babur
    K J Williams
    E J Dean
    C Dive
    F H Blackhall
    A White
    British Journal of Cancer, 2013, 108 : 1704 - 1711
  • [42] Neuroendocrine and epithelial phenotypes in small-cell lung cancer: implications for metastasis and survival in patients
    Stovold, R.
    Meredith, S. L.
    Bryant, J. L.
    Babur, M.
    Williams, K. J.
    Dean, E. J.
    Dive, C.
    Blackhall, F. H.
    White, A.
    BRITISH JOURNAL OF CANCER, 2013, 108 (08) : 1704 - 1711
  • [43] Will Rogers phenomenon in small-cell lung cancer
    Rubiales, A. Sanz
    del Valle, M. L.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2007, 9 (03): : 201 - 201
  • [44] Multiple myeloma and small-cell lung cancer
    Villas, JMC
    Sánchez, MJR
    Tovar, JC
    Guillén, FJS
    REVISTA CLINICA ESPANOLA, 2001, 201 (05): : 294 - 295
  • [45] SMALL-CELL LUNG-CANCER AND TOPOISOMERASES
    GIACCONE, G
    ANTICANCER RESEARCH, 1994, 14 (1B) : 269 - 276
  • [46] CHEMOTHERAPY IN SMALL-CELL LUNG-CANCER
    RUFFIE, P
    LECHEVALIER, T
    BULLETIN DU CANCER, 1987, 74 (05) : 531 - 540
  • [47] Timing of treatment in small-cell lung cancer
    Shruti Bhandari
    Danh Pham
    Christina Pinkston
    Malgorzata Oechsli
    Goetz Kloecker
    Medical Oncology, 2019, 36
  • [48] Modern management of small-cell lung cancer
    Ferraldeschi, Roberta
    Baka, Sofia
    Jyoti, Babita
    Faivre-Finn, Corinne
    Thatcher, Nick
    Lorigan, Paul
    DRUGS, 2007, 67 (15) : 2135 - 2152
  • [49] Chemotherapy of non small-cell lung cancer
    Le Guen, Y
    Soria, JC
    Ruffié, P
    BULLETIN DU CANCER, 2003, 90 (03) : 199 - 201
  • [50] Irinotecan therapy for small-cell lung cancer
    Sandler, A
    ONCOLOGY-NEW YORK, 2002, 16 (04): : 419 - +